Department of Radiation Oncology, Fortis Memorial Research Institute, Gurgaon, Haryana, India.
Department of Radiology, Fortis Memorial Research Institute, Gurgaon, Haryana, India.
J Cancer Res Ther. 2020 Oct-Dec;16(6):1488-1494. doi: 10.4103/jcrt.JCRT_1151_19.
T1-contrast and T2-flair images of magnetic resonance imaging (MRI) are commonly fused with computed tomography (CT) and used for delineation of postoperative residual tumor and bed after surgery in patients with glioblastoma multiforme (GBM). Our prospective study was aimed to see the feasibility of incorporating perfusion MRI in delineation of brain tumor for radiotherapy planning and its implication on treatment volumes.
Twenty-four patients with histopathologically proven GBM were included in the study. All patients underwent radiotherapy planning with a contrast CT scan. In addition to radiotherapy (RT) planning protocol, T1-perfusion MRI was also done in all patients in the same sitting. Perfusion imaging was processed on the in-house-developed JAVA-based software. The images of CT and MRI were sent to the iPlan planning system (Brainlab AG, GmbH) using a Digital Imaging and Communications in Medicine - Radiation Therapy (DICOM-RT) protocol. A structure of gross tumor volume (GTV)-perfusion (GTV-P) was delineated based only on the MRI perfusion images. Subsequently, GTV-P and GTV were fused together to make GTV-summated (GTV-S). Using existing guidelines, GTV-S was expanded to form clinical target volume-summated (CTV-S) and planning target volume-summated (PTV-S). The increment in each of the summated volumes as compared to baseline volume was noted. The common overlap volume (GTVO) between GTV and GTV-P was calculated using intersection theory (GTV n GTV-P = GTVO [Overlap]).
Mean ± standard deviation (cc) for GTV, GTV-P, and GTVO was 46.3 ± 33.4 cc (range: 5.2 cc-108.0 cc), 26.0 ± 26.2 (range: 6.6 cc-10.3.0 cc), and 17.5 ± 22.3 cc (range: 10.0 cc-92 cc), respectively. Median volume (cc) for GTV, GTV-P, and GTVO was 40.8 cc, 17.2 cc, and 8.0 cc, respectively. Mean absolute and relative increments from GTV to that of GTV-S were 8.5 ± 8.2 cc and 27.2 ± 30.9%, respectively. Average CTV volume (cc) was 230.4 ± 115.3 (range: 80.8 cc-442.0 cc). Mean and median CTV-S volumes were 262.0 ± 126.3 cc (range: 80.8 cc-483.0 cc) and 221.0 cc, respectively. The increment in the mean CTV volume (with respect to CTV created from GTV-S) was 15.2 ± 15.9%. Mean and median PTV volumes created on the summated CTV were 287.1 ± 134.0 cc (range: 118.9 cc-576.0 cc) and 258.0 cc, respectively. Absolute and relative increments in PTV volume, while incorporating the perfusion volume, were 31.3 ± 28.9 cc and 12.5 ± 13.3%, respectively. Out of the total of 24 patients, perfusion scanning did not do any increment in GTV in five patients.
Our study is the first to present the feasibility and the outcome of contouring on perfusion imaging and its overlay on regular MRI images. The implications of this on long-term outcome and control rates of glioblastoma patients need to be seen in future studies.
磁共振成像(MRI)的 T1 对比和 T2 加权图像通常与计算机断层扫描(CT)融合,用于描绘胶质母细胞瘤(GBM)患者手术后残留肿瘤和肿瘤床。我们的前瞻性研究旨在探讨将灌注 MRI 纳入脑肿瘤放疗计划的可行性及其对治疗体积的影响。
本研究纳入了 24 例经组织病理学证实的 GBM 患者。所有患者均接受了对比 CT 扫描的放疗计划。除了 RT 计划方案外,所有患者还在同一次就诊中进行了 T1 灌注 MRI。灌注成像在内部开发的基于 JAVA 的软件上进行处理。使用数字成像和通信在放射治疗(DICOM-RT)协议将 CT 和 MRI 图像发送到 iPlan 计划系统(Brainlab AG,GmbH)。仅基于 MRI 灌注图像勾勒出大体肿瘤体积(GTV)-灌注(GTV-P)结构。随后,将 GTV-P 和 GTV 融合在一起,形成 GTV 总和(GTV-S)。根据现有指南,将 GTV-S 扩展形成临床靶区总和(CTV-S)和计划靶区总和(PTV-S)。记录与基线体积相比每个总和体积的增量。使用交集理论(GTV n GTV-P = GTVO [重叠])计算 GTV 和 GTV-P 之间的共同重叠体积(GTVO)。
GTV、GTV-P 和 GTVO 的平均值±标准差(cc)分别为 46.3±33.4 cc(范围:5.2 cc-108.0 cc)、26.0±26.2 cc(范围:6.6 cc-10.3.0 cc)和 17.5±22.3 cc(范围:10.0 cc-92 cc)。GTV、GTV-P 和 GTVO 的中位数体积(cc)分别为 40.8 cc、17.2 cc 和 8.0 cc。GTV 到 GTV-S 的绝对和相对增量分别为 8.5±8.2 cc 和 27.2±30.9%。平均 CTV 体积(cc)为 230.4±115.3(范围:80.8 cc-442.0 cc)。GTV-S 的平均和中位数 CTV-S 体积分别为 262.0±126.3 cc(范围:80.8 cc-483.0 cc)和 221.0 cc。CTV 体积的平均增量(与基于 GTV-S 的 CTV 相比)为 15.2±15.9%。GTV 总和上创建的 PTV 的平均和中位数体积分别为 287.1±134.0 cc(范围:118.9 cc-576.0 cc)和 258.0 cc。纳入灌注体积后,PTV 体积的绝对和相对增量分别为 31.3±28.9 cc 和 12.5±13.3%。在 24 名患者中,灌注扫描在 5 名患者中未增加 GTV。
我们的研究首次提出了在常规 MRI 图像上勾画灌注图像及其重叠的可行性和结果。这对胶质母细胞瘤患者的长期预后和控制率的影响需要在未来的研究中进一步观察。